相关实验视频
Updated: Jun 18, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
使用免疫检查点抑制剂和氨酸酶抑制剂或化剂的组合疗法
Markus Joerger1, Kira-Lee Koster1, Tomas Janik2
1Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Cancer management and research
|July 29, 2024
概括
将免疫检查点抑制剂 (CPI) 与化剂 (AAs) 或基因脱乙酶抑制剂 (HDACis) 结合起来,对各种癌症具有前景. 对这些协同作用的癌症治疗方法的进一步研究是有必要的.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫检查点抑制剂 (CPI) 是许多癌症的治疗方法.
- 基因组脱乙酶抑制剂 (HDACis) 和化剂 (AAs) 可能会提高CPI的疗效.
- 了解潜在的协同相互作用对于推进癌症治疗至关重要.
研究的目的:
- 进行关于CPI与AA和/或HDAC结合的协同作用的综合文献审查.
- 探索这些组合在各种恶性瘤中的潜力.
- 为了识别并发与顺序给予策略中的模式.
主要方法:
- 在PubMed的系统文献搜索和瘤学大会摘要.
- 包括关于CPI,AA和HDAC的临床和非临床研究.
- 根据药物类型,瘤实体和治疗顺序对研究进行分类.
主要成果:
- 在固体瘤和血液性恶性瘤中确定了227项独特的临床研究.
- 结合CPI与AA的随机试验显示,与单一治疗相比,结果更好.
- 与CPI和HDAC结合治疗显示出有前途的抗癌活性.
结论:
- 与AAs或HDACis连续或同时使用的CPI可能会改善各种瘤类型的患者结果.
- 对CPI,AA和HDACi的协同作用进行进一步调查有很强的理由.
- 这些组合代表了未来癌症治疗策略的有希望的途径.
相关概念视频
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

